Expression and clinical significance of heparanase and Ki-67 in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 12, Issue 7, 2009, Pages 785-788

  Song, Zuoqing ^a   Xu, Xiaohong ^a   Wei, Sen ^a   Chen, Jun ^a   Liu, Yi ^a   Li, Xin ^a   Zhao, Honglin ^a   Qiu, Xiaoming ^a   Zhou, Naikang ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Heparanase; Immunohistochemistry; Ki 67; Lung neoplasms

Indexed keywords

HEPARANASE; KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 70349322250     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.07.008     Document Type: Article

References (12)

1. Ilan N, Elkin M, Vlodavsky, et al. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol, 2006, 38(12): 2018-2039. (Pubitemid 44397619)
2. Sajnani-Perez G, Chilton JK, Aricescu AR, et al. Isoform-specific binding of the tyrosine phosphatase PTP sigma to a ligand in developing muscle. Mol Cell Neurosci, 2003, 22(1): 37-48. (Pubitemid 36269114)
3. Okawa T, Naomoto Y, Nobuhisa T, et al. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin Cancer Res, 2005, 11(22): 7995-8005. (Pubitemid 41698740)
4. Sommerfeldt N, Beckhove P. Heparanase: a new metastasis-associated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytes. Cancer Res, 2006, 66(15): 7716-7723. (Pubitemid 44289231)
5. Xie ZJ, Liu Y, Jia LM, et al. Heparanase expression, degradation of basement membrane and low degree of infiltration by immunocytes correlate with invasion and progression of human gastric cancer. World J Gastroenterol, 2008, 14(24): 3812-3818.
6. Quiros RM, Rao G, Plate J, et al. Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer, 2006, 106(3): 532-540 . (Pubitemid 43157615)
7. Shafati, Pode D, Peretz T, et al. Clinical significance of urine heparanase in bladder cancer progression. Neoplasia, 2008, 10(2): 125-130. (Pubitemid 351240878)
8. Taheri ZM, Mehrafza M, Mohammadi F, et al. The diagnostic value of Ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations. Arch Pathol Lab Med, 2008, 132(4): 694-697.
9. Song ZQ, Xu XH, Wei S, et al. The expression and clinical significance of heparanase in non-small cell lung cancer. Chin J Lung Cancer, 2008, 11(6): 798-801.
10. Chen XL, Zhang WG, Chen XY, et al. Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer. Ai Zheng, 2006, 25(9): 1134-1137.
11. Endo K, Maejara U, Baba H, et al. Heparanase gene expression and metastatic potential in human gastric cancer. Anticancer Res, 2001, 21(5): 3365-3369. (Pubitemid 34224238)
12. Sardari Nia P, Colpaert C, Vermeulen P, et al. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. Ann Thorac Surg, 2008, 85(2): 395-405.